NO20021803L - Isoksazolkarboksamid-derivater - Google Patents

Isoksazolkarboksamid-derivater

Info

Publication number
NO20021803L
NO20021803L NO20021803A NO20021803A NO20021803L NO 20021803 L NO20021803 L NO 20021803L NO 20021803 A NO20021803 A NO 20021803A NO 20021803 A NO20021803 A NO 20021803A NO 20021803 L NO20021803 L NO 20021803L
Authority
NO
Norway
Prior art keywords
isoksazolkarboksamid
derivatives
isoksazolkarboksamid derivatives
Prior art date
Application number
NO20021803A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021803D0 (no
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Riva
Elena Poggesi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of NO20021803D0 publication Critical patent/NO20021803D0/no
Publication of NO20021803L publication Critical patent/NO20021803L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20021803A 1999-10-18 2002-04-17 Isoksazolkarboksamid-derivater NO20021803L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002173A IT1314191B1 (it) 1999-10-18 1999-10-18 Derivati isossazolcarbossamidici
PCT/EP2000/010144 WO2001029015A2 (en) 1999-10-18 2000-10-16 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists

Publications (2)

Publication Number Publication Date
NO20021803D0 NO20021803D0 (no) 2002-04-17
NO20021803L true NO20021803L (no) 2002-06-17

Family

ID=11383797

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021803A NO20021803L (no) 1999-10-18 2002-04-17 Isoksazolkarboksamid-derivater

Country Status (25)

Country Link
EP (1) EP1226131B1 (it)
JP (1) JP2003512362A (it)
KR (1) KR20020038944A (it)
CN (1) CN1139579C (it)
AR (1) AR029400A1 (it)
AT (1) ATE256670T1 (it)
AU (1) AU757614B2 (it)
BR (1) BR0014851A (it)
CA (1) CA2385472A1 (it)
DE (1) DE60007347T2 (it)
DK (1) DK1226131T3 (it)
ES (1) ES2210033T3 (it)
HK (1) HK1044940A1 (it)
HU (1) HUP0203184A3 (it)
IL (1) IL148837A0 (it)
IT (1) IT1314191B1 (it)
MX (1) MXPA02003432A (it)
MY (1) MY120400A (it)
NO (1) NO20021803L (it)
NZ (1) NZ517884A (it)
PL (1) PL356990A1 (it)
PT (1) PT1226131E (it)
RU (1) RU2002113096A (it)
WO (1) WO2001029015A2 (it)
ZA (1) ZA200203942B (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1937674A1 (en) 2005-10-11 2008-07-02 F.Hoffmann-La Roche Ag Isoxazole derivatives
BRPI0618383A2 (pt) 2005-11-09 2011-08-30 Hoffmann La Roche derivados de 3-aril-isoxazol-4-carbonil-benzofurano
CA2633425A1 (en) 2005-12-23 2007-06-28 F. Hoffmann-La Roche Ag Aryl-isoxazolo-4-yl-oxadiazole derivatives
DK1968973T3 (da) 2005-12-27 2011-10-31 Hoffmann La Roche Aryl-isoxazol-4-yl-imidazolderivater
CA2636112A1 (en) 2006-01-17 2007-07-26 F.Hoffmann-La Roche Ag Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives useful for the treatment of alzheimer's disease via gaba receptors
ES2328185T3 (es) 2006-05-31 2009-11-10 F. Hoffmann-La Roche Ag Derivados de aril-4-etinil-isoxazol.
EP2170873B1 (en) 2007-06-22 2011-08-10 F. Hoffmann-La Roche AG Isoxazole-imidazole derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
US7902201B2 (en) 2007-12-04 2011-03-08 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
MX2010005753A (es) 2007-12-04 2010-06-15 Hoffmann La Roche Derivados de isoxazolo-pirazina.
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
TW201033201A (en) 2009-02-19 2010-09-16 Hoffmann La Roche Isoxazole-isoxazole and isoxazole-isothiazole derivatives
US8389550B2 (en) 2009-02-25 2013-03-05 Hoffmann-La Roche Inc. Isoxazoles / O-pyridines with ethyl and ethenyl linker
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
US20100280019A1 (en) 2009-04-30 2010-11-04 Roland Jakob-Roetne Isoxazoles
US8178522B2 (en) 2009-05-05 2012-05-15 Hoffmann-La Roche Inc. Thiazoles
SG175867A1 (en) 2009-05-05 2011-12-29 Hoffmann La Roche Isoxazole-pyridine derivatives
JP5460858B2 (ja) 2009-05-05 2014-04-02 エフ.ホフマン−ラ ロシュ アーゲー イソオキサゾール−ピラゾール誘導体
MX2011011477A (es) 2009-05-05 2011-11-18 Hoffmann La Roche Derivados de isoxazol-piridazina.
WO2010127978A1 (en) 2009-05-07 2010-11-11 F. Hoffmann-La Roche Ag Isoxazole-pyridine derivatives as gaba modulators
US8785435B2 (en) 2011-10-20 2014-07-22 Hoffmann-La Roche Inc. Solid forms
CN113121540B (zh) * 2020-01-15 2024-01-26 鲁南制药集团股份有限公司 一种西格列汀游离碱的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen

Also Published As

Publication number Publication date
EP1226131B1 (en) 2003-12-17
JP2003512362A (ja) 2003-04-02
HK1044940A1 (zh) 2002-11-08
RU2002113096A (ru) 2003-11-10
IT1314191B1 (it) 2002-12-06
PT1226131E (pt) 2004-05-31
DE60007347T2 (de) 2004-09-02
WO2001029015A3 (en) 2001-11-01
HUP0203184A2 (hu) 2003-01-28
NZ517884A (en) 2003-08-29
EP1226131A2 (en) 2002-07-31
KR20020038944A (ko) 2002-05-24
PL356990A1 (en) 2004-07-12
ATE256670T1 (de) 2004-01-15
ZA200203942B (en) 2003-01-02
AU2834701A (en) 2001-04-30
CA2385472A1 (en) 2001-04-26
AR029400A1 (es) 2003-06-25
IL148837A0 (en) 2002-09-12
MXPA02003432A (es) 2002-08-20
HUP0203184A3 (en) 2004-12-28
ITMI992173A1 (it) 2001-04-18
ES2210033T3 (es) 2004-07-01
WO2001029015A2 (en) 2001-04-26
ITMI992173A0 (it) 1999-10-18
CN1379767A (zh) 2002-11-13
BR0014851A (pt) 2002-06-11
DK1226131T3 (da) 2004-04-19
NO20021803D0 (no) 2002-04-17
CN1139579C (zh) 2004-02-25
MY120400A (en) 2005-10-31
AU757614B2 (en) 2003-02-27
DE60007347D1 (de) 2004-01-29

Similar Documents

Publication Publication Date Title
IS2116B (is) 4-fenyl-pyridin afleiður
NO20021077L (no) Amino-triazolopyridin-derivater
DE60009747D1 (de) Admantan-derivate
ATE293104T1 (de) Thiazolylamid-derivate
EE200100613A (et) 13-metüülerütromütsiini derivaadid
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
DE50013404D1 (de) Substituierte 2-dialkylaminoalkylbiphenyl-derivate
NO20021803D0 (no) Isoksazolkarboksamid-derivater
PT1237857E (pt) Novos derivados fenalquiloxi-fenilo
ATE257148T1 (de) Propargyletherderivate
DK1154988T3 (da) Mevinolinderivater
ATE374747T1 (de) Monofluoralkylderivate
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de) Resorcinderivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
NO20022867D0 (no) Syklopentenon-derivater
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
TR200002831A3 (tr) Kinolin-4-Il türevleri I
DK1189886T3 (da) Ethansulfonyl-piperidinderivater
DK1178984T3 (da) 1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application